| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2830 | |||||||||||||||||||||||
| Submitter : | Ms. R Moyer | Date & Time: | 12/11/2006 10:12:56 | |||||||||||||||||||||
| Organization : | Ms. R Moyer | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| A a consumer concerned with both moral values and the health of my family, I request government intervention to ensure the creation of vaccines from non-objectionable sources, which are plentiful. | ||||||||||||||||||||||||